Genscript Biotech Corporation is a global biotech company. The Company's mission is to "Make the Human and Nature Healthier through Biotechnology". Genscript Biotech Corporation is a leading life sciences research and application service and product provider that applies its proprietary technology to various fields from basic life sciences research to translational biomedical development, industrial synthetic products, and cell therapeutic solutions. Read More »
Leveraging in the Group's proprietary gene synthesis and other technology and know-hows, the Group has established four major platforms including (i) a leading contracted research organization ("CRO") platform to provide one-stop solutions to global research communities; (ii) a contract development and manufacturing organization ("CDMO") platform; (iii) an industrial synthetic products platform; and (iv) an integrated global cell therapy platform. The CRO platform remains as the strong and stable revenue generating foundation for the entire corporate. The CDMO platform provides end-to-end biologics discovery and development services to pharmaceutical, biotech, government and academic customers worldwide. The industrial synthetic products platform develops products for food and feed processing and other industrial uses. The cell therapy platform provides cell therapy solutions to patients with refractory diseases including cancer and inflammatory diseases.
2022 Interim Results Conference
2022-09-01
41st JPM Annual Healthcare Meeting
2023-01-09 ~ 01-12
Virtual Conference
2022 Interim Results Conference
2022-09-01
Virtual Conference
Asia Healthcare Corporate Day
2022-07-15
Virtual Conference
Registered office in the Cayman Islands
4th Floor, Harbour Place
103 South Church Street, George
Town P.O. Box 10240, Grand Cayman KYI-1002
Cayman Islands
Company
secretary
Ms. Wong Wai Ling (黄慧玲)
(a member of the Hong Kong Institute of Chartered Secretaries)
Company
websites
www.genscript.com
www.bestzyme.com
(information contained in these websites does not form part of this prospectus)
Authorized
representatives
Mr. Meng Jiange (孟建革)
Dr. Zhu Li (朱力)
Principal share registrar and transfer office
Harneys Services (Cayman) Limited
4th Floor, Harbour Place
103 South Church Street George Town
P.O. Box 10240
Grand Cayman KYI-1002
Cayman Islands
Hong Kong share registrar
Computershare Hong Kong Investor Services Limited
Shop 1712-1716
17th Floor, Hopewell Centre
183 Queen's Road East
Wan Chai
Hong Kong